Natralia Eczema and Psoriasis (LaCorium Health USA Inc.)
Welcome to the PulseAid listing for the Natralia Eczema and Psoriasis drug offered from LaCorium Health USA Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | LaCorium Health USA Inc. |
| NON-PROPRIETARY NAME: | Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride |
| SUBSTANCE NAME: | SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2009-01-03 |
| END MARKETING DATE: | 0000-00-00 |
Natralia Eczema and Psoriasis HUMAN OTC DRUG Details:
| Item Description | Natralia Eczema and Psoriasis from LaCorium Health USA Inc. |
| LABELER NAME: | LaCorium Health USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 6; 3; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL) |
| START MARKETING DATE: | 2009-01-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43251-2281_b25244bc-84d5-4f2b-9ee4-a36de135c595 |
| PRODUCT NDC: | 43251-2281 |
| APPLICATION NUMBER: | |
Other SODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
